https://padlet.com/plwilson4/ot8i298wruw6 fill in the missing words en-us 2016-12-13 04:01:08 UTC 2016-12-13 04:11:18 UTC hello@padlet.com plwilson4 https://padlet.com/plwilson4/ot8i298wruw6/wish/143275489 THE EXPENSE OF drug manufacturing
becomes an even greater concern when
making drugs for the developing world.
Pharmaceutical companies have a tendency
to develop drugs for wealthier countries to
ensure investment return, while diseases
affecting people in poorer countries are
neglected. Malaria is a case in point.
Artemisinin is a drug active against
the malaria parasite, extracted from the
Artemisia annua plant, also known as a type
of wormwood. It's been used for centuries
and is probably one of the best-known
plant-derived medical products. Currently
the drug is extracted and purified from fieldgrown
plants; however, the plants' yield
of active ingredient is around 1-2% of dry
weight- which isn't enough to treat malaria.
Plant biotechnologist Pam Weathers
and her colleagues have suggested an
alternative low-technology method for
increasing the drug's accessibility, and
maybe even combatting recently emerging
artemisinin-resistant forms of the disease.
"Artemisinin was used by the Chinese]]> 2016-12-13 04:10:36 UTC https://padlet.com/plwilson4/ot8i298wruw6/wish/143275489